Company intelligence / Profile preview
Canada Royal Enoch Phytomedicine Ltd.
Vancouver, British Columbia, Canadaenophyto.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
The company launched a clinical trial of its ginseng-derived Redsenol-1 Plus Noble Ginsenoside Capsules in January 2023. In March 2025, their product Redsenol-1 Plus was included in the National Cancer Institute's Drug Dictionary, highlighting its potential in oncology and supportive care.
- Therapeutic areas
- OncologyOther
- Modalities
- Plant-based natural productsGinsenoside supplements
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Canada Royal Enoch Phytomedicine Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canada Royal Enoch Phytomedicine Ltd..